Schizophrenia.com

OWP Pharmaceuticals Announces Patent Issuance for the First-Ever Oral Liquid Suspension of Quetiapine for the Treatment of Schizophrenia and Bipolar Disorder

everhopeful July 1, 2021, 12:39pm 1

Topic		Replies	Views	Activity
Zysis Receives US Patent for Long Acting Oral Aripiprazole Once Weekly Medications	1	758	November 13, 2013
Impel Neuropharma Announces Positive Phase 1 Trial For INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia News	0	239	January 6, 2019
New Liquid Version of Clozapine Available News	3	3663	February 12, 2014
Letter from GWPharma Medications	5	998	May 31, 2016
Quetiapine for schizophrenia: more transparency needed in clinical trial reporting Medications	3	721	June 16, 2015